Subscribe to RSS
DOI: 10.1055/s-2007-973863
First Enantioselective Total Synthesis of the Angucyclinone-Type Antibiotic YM-181741
Publication History
Publication Date:
26 March 2007 (online)
Abstract
A simple and efficient strategy for angucyclinone antibiotics is described with the disclosure of first total synthesis of YM-181741.
Key words
Grubbs’ catalyst - enyne metathesis - Diels-Alder reaction - quinones - angucyclinone antibiotic
-
1a
Peterson WL. N. Engl. J. Med. 1991, 324: 1043 -
1b
Van der Hults RWM.Rauws EAJ.Koycu B.Keller JJ.Bruno MJ.Tussen JGP.Tytgat GNJ. Gastroenterology 1997, 113: 1082 -
2a
Domizio P.Farthing MJG. Aliment. Pharmacol. Ther. 1995, 9: 205 -
2b
Megraud F. Brit. Med. Bull. 1998, 54: 207 - 3
Taniguchi M.Nagai K.Watanabe M.Niimura N.Suzuki K.-I.Tanaka A. J. Antibiot. 2002, 55: 30 - 4
Bowie JH.Johnson W. Tetrahedron Lett. 1967, 34: 1449 -
5a
Rohr J.Thiericke R. Nat. Prod. Rep. 1992, 9: 103 -
5b
Carreño MC.Urbano A. Synlett 2005, 1 - For sequential enyne metathesis and Diels-Alder reaction with quinones as well as other dienophiles, see:
-
6a
Kaliappan KP.Ravikumar V. Org. Biomol. Chem. 2005, 848 -
6b
Dolhem F.Lievre C.Demailly G. Eur. J. Org. Chem. 2003, 2336 -
6c
Yang Y.-K.Tae J. Synlett 2003, 2017 -
6d
Guo H.Madhushaw RJ.Shen F.-M.Liu R.-S. Tetrahedron 2002, 58: 5627 -
6e
Moreno-Mañas M.Pleixats R.Santamaria A. Synlett 2001, 1784 -
6f
Kotha S.Sreenivasachary N.Brahmachary E. Eur. J. Org. Chem. 2001, 787 -
6g
Bentz D.Laschat S. Synthesis 2000, 1766 - For selected examples of utility of Diels-Alder reaction in the synthesis of angucyclinone, see:
-
7a
Krohn K.Sohrab MH.Flörke U. Tetrahedron: Asymmetry 2004, 15: 713 -
7b
Landells JS.Larsen DS.Simpson J. Tetrahedron Lett. 2003, 44: 5193 -
7c
Krohn K.Michael J.Zukowski M. Tetrahedron 2000, 56: 4753 -
7d
Matsuo G.Miki Y.Nakata M.Matsumura S.Toshima K. J. Org. Chem. 1999, 64: 7101 -
7e
Carreño MC.Urbano A.Fischer J. Angew. Chem., Int. Ed. Engl. 1997, 36: 1621 -
7f
Matsuo G.Miki Y.Nakata M.Matsumura S.Toshima K. Chem. Commun. 1996, 225 -
7g
Kim K.Sulikowski GA. Angew. Chem., Int. Ed. Engl. 1995, 34: 2396 -
7h
Datta SC.Franck RW.Triphaty R.Quigley GJ.Huang L.Chen S.Sihaed A. J. Am. Chem. Soc. 1990, 112: 8472 -
7i
Carreño MC.Somoza A.Ribagorda M.Urbano A. Chem. Eur. J. 2007, 23: 879 - 8
Ghosh AK.Gong G. J. Org. Chem. 2006, 71: 1085 - 9
Hu X.Nguyen KT.Verlinde CLMJ.Hol WGJ.Pei D. J. Med. Chem. 2003, 46: 3771 - 10
Pettigrew JD.Wilson PD. Org. Lett. 2006, 8: 1427 - 12
Mori M.Sakakibara N.Kinoshita A. J. Org. Chem. 1998, 63: 6082 - For reviews on enyne metathesis, see:
-
13a
Mori M. Top. Organomet. Chem. 1998, 1: 133 -
13b
Poulsen CS.Madsen R. Synthesis 2003, 1 -
13c
Diver ST.Giessert J. Chem. Rev. 2004, 104: 1317 - 14
Heinzman SW.Grunwell JR. Tetrahedron Lett. 1980, 21: 4305 -
15a
Krohn K.Ballwanz F.Baltus W. Liebigs Ann. Chem. 1993, 911 -
15b
Motoyoshiya J.Masue Y.Iwayama G.Yoshioka S.Nishii Y.Aoyama H. Synthesis 2004, 2099
References and Notes
HPLC conditions: YMC Pack Pro-C18, 4.6 × 250 mm, eluents H2O-MeCN (10:90), flow 1.0 mL/min, UV detector at 254 nm; t R = 2.928 min.
16
Spectral Data for Selected Compounds
Diene 15: R
f
= 0.9 (EtOAc-PE, 3:7); [α]D
20 +99.1 (c 1.35, CHCl3). IR (neat): 3454, 2930, 1655, 1465, 1257, 1104 cm-1. 1H NMR (400 MHz, CDCl3): δ = 6.37 (2 H, dd, J = 17.6, 10.8 Hz), 5.75 (1 H, br s), 5.07 (1 H, d, J = 17.7 Hz), 4.9 (1 H, d, J = 10.8 Hz), 3.59-3.49 (2 H, m), 2.30-2.18 (2 H, m), 2.30-2.18 (1 H, m), 1.80-1.76 (2 H, m), 1.29-1.20 (1 H, m), 0.89 (9 H, s), 0.06 (6 H, s). 13C NMR (75 MHz, CDCl3): δ = 140.0, 135.3, 129.6, 109.8, 67.9, 36.3, 26.9, 26.0, 25.3, 18.4, -5.4, -5.3.
Compound 18: R
f
= 0.4 (EtOAc-PE, 1:19); mp 86-88 °C; [α]D
20 +130.0 (c 0.9, CHCl3). IR (KBr): 3444, 2896, 2930, 1667, 1634, 1454, 1284, 1256, 1107 cm-1. 1H NMR (300 MHz, CDCl3): δ = 12.55 (1 H, s), 8.14 (1 H, d, J = 8.4 Hz), 7.72 (1 H, dd, J = 7.6, 1.2 Hz), 7.64 (1 H, t, J = 7.8 Hz), 7.50 (1 H, d, J = 7.6 Hz), 7.24 (1 H, dd, J = 8.4, 1.2 Hz), 3.68-3.29 (2 H, m), 3.28-3.20 (1 H, m), 3.00 (1 H, dd, J = 17.2, 2.8 Hz), 2.67 (1 H, dd, J = 17.2, 10.8 Hz), 2.09-2.0 (2 H, m), 1.47-1.25 (1 H, m), 3.05-2.81 (2 H, m), 0.92 (9 H, s), 0.07 (6 H, s). 13C NMR (100 MHz, CDCl3): δ = 188.8, 161.9, 146.2, 141.7, 136.6, 136.5, 135.1, 135.0, 132.8, 131.2, 124.8, 123.1, 119.4, 115.7, 67.5, 35.7, 34.5, 28.9, 26.1, 18.5, -5.1, -5.2; HRMS (EI): m/z calcd for C25H31O4Si: 423.1992; found: 423.1981.
Ketone 19: R
f
= 0.33 (EtOAc-PE, 1:9); mp 91-93 °C; [α]D
20 +56.5 (c 0.52, CHCl3). IR (KBr): 3425, 2927, 1706, 1672, 1592, 1457, 1363, 1284, 1099 cm-1. 1H NMR (300 MHz, CDCl3): δ = 12.30 (1 H, s), 8.30 (1 H, d, J = 7.8 Hz), 7.69 (1 H, dd, J = 5.4, 1.8 Hz), 7.65 (1 H, d, J = 7.8 Hz), 7.58 (1 H, d, J = 8.1 Hz), 7.28 (1 H, dd, J = 8.1, 2.1 Hz), 3.71 (1 H, dd, J = 9.9, 5.1 Hz), 3.62 (1 H, dd, J = 10.2, 6.3 Hz), 3.05-2.81 (2 H, m), 2.73 (2 H, dd, J = 16.2, 10.8 Hz), 2.56-2.49 (1 H, m), 0.91 (9 H, s), 0.07 (6 H, s). 13C NMR (100 MHz, CDCl3): δ = 199.3, 187.6, 183.0, 162.2, 150.4, 137.2, 136.9, 135.8, 135.1, 133.5, 133.4, 129.1, 123.8, 119.8, 115.5, 66.2, 42.3, 38.0, 33.0, 26.0, 18.4, -5.3. HRMS (EI): m/z calcd for C25H29O5Si: 437.1784; found: 437.1779.
Natural product YM 181741 (1): 68% yield (0.05 g); R
f
= 0.3 (EtOAc-PE, 6:4); mp 192 °C; [α]D
25 +27.2 (c 0.367, CHCl3). IR (KBr): 3433, 2927, 1702, 1671, 1588, 1453, 1362, 1276, 1588, 1453, 1362, 1276, 1215 cm-1. UV (MeOH): λmax (ε) = 276, 402 nm. 1H NMR (400 MHz, CDCl3): δ = 12.30 (1 H, s), 8.30 (1 H, d, J = 7.6 Hz), 7.68 (1 H, dd, J = 7.6, 2.4 Hz), 7.65 (1 H, d, J = 7.2 Hz), 7.58 (1 H, d, J = 8 Hz), 7.28 (1 H, dd, J = 8.0, 2.4 Hz), 3.77 (1 H, dd, J = 10.4, 4.8 Hz), 3.70 (1 H, dd, J = 7.2, 10.4 Hz), 3.10 (1 H, dd, J = 16.8, 4.8 Hz), 3.03 (1 H, dd, J = 16, 6.4 Hz), 2.85 (1 H, dd, J = 16.4, 10.4 Hz), 2.69 (1 H, dd, J = 16.0, 10.4 Hz), 2.61-2.54 (1 H, m), 1.86 (1 H, br s). 13C NMR (100 MHz, CDCl3): δ = 198.8, 187.4, 182.9, 162.0, 149.8, 137.0, 136.7, 135.6, 134.9, 133.5, 133.2, 129.1, 123.8, 119.6, 115.4, 65.8, 42.0, 37.6, 32.7. HRMS (EI): m/z calcd for C19H15O5: 323.0919; found: 323.0910.